The estimated Net Worth of Gregory J. Flesher is at least $2.32 millió dollars as of 20 May 2019. Gregory Flesher owns over 14,638 units of Novus Therapeutics Inc stock worth over $2,291,003 and over the last 8 years Gregory sold NVUS stock worth over $28,544.
Sign up
Gregory Flesher NVUS stock SEC Form 4 insiders trading
Gregory has made over 2 trades of the Novus Therapeutics Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently Gregory sold 14,638 units of NVUS stock worth $28,544 on 20 May 2019.
The largest trade Gregory's ever made was buying 58,959 units of Novus Therapeutics Inc stock on 10 May 2017 worth over $589,000. On average, Gregory trades about 10,514 units every 106 days since 2017. As of 20 May 2019 Gregory still owns at least 156,918 units of Novus Therapeutics Inc stock.
You can see the complete history of Gregory Flesher stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Gregory Flesher's mailing address?
Gregory's mailing address filed with the SEC is C/O NOVUS THERAPEUTICS, INC, 19900 MACARTHUR BLVD., SUITE 550, IRVINE, CA, 92612.
Insiders trading at Novus Therapeutics Inc
Over the last 8 years, insiders at Novus Therapeutics Inc have traded over $2,287,089 worth of Novus Therapeutics Inc stock and bought 1,499,013 units worth $7,312,148 . The most active insiders traders include Partners L P/Ilbiotechnolog..., Israel Gp Ltd.Orbi Med Isra... és Erez Chimovits. On average, Novus Therapeutics Inc executives and independent directors trade stock every 100 days with the average trade being worth of $1,832,709. The most recent stock trade was executed by Israel Gp Ltd.Orbi Med Isra... on 2 December 2020, trading 103,200 units of NVUS stock currently worth $2,229,120.
What does Novus Therapeutics Inc's logo look like?
Complete history of Gregory Flesher stock trades at Novus Therapeutics Inc
Novus Therapeutics Inc executives and stock owners
Novus Therapeutics Inc executives and other stock owners filed with the SEC include:
-
John McBride,
Director -
Jon Kuwahara,
Chief Financial Officer, Chief Accounting Officer -
Keith Katkin,
Independent Chairman of the Board -
Walter Ogier,
Independent Director -
David-Alexandre Gros,
Chief Executive Officer, Director -
Steven Perrin,
President, Chief Scientific Officer -
Gary Lyons,
Independent Director -
Christine Ocampo,
See Remarks -
Israel Gp Ltd.Orbi Med Isra...,
-
Cheryl Cohen,
Director -
Jodie Pope Morrison,
Director -
Erez Chimovits,
Director -
Index Partners Llcyook Paul...,
-
Gregory J. Flesher,
Chief Executive Officer -
Catherine C. Turkel,
President -
Global Management Lp Logos,
10% owner -
Partners L P/Ilbiotechnolog...,